(Q42651308)

English

Neurocognition and its influencing factors in the treatment of schizophrenia-effects of aripiprazole, olanzapine, quetiapine and risperidone

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

0 references

Neurocognition and its influencing factors in the treatment of schizophrenia-effects of aripiprazole, olanzapine, quetiapine and risperidone (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

0 references

Florian Seemüller

8

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Hans-Jürgen Möller

12

object named as

H-J Möller

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

author name string

M Riedel

1

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

R Schennach-Wolff

2

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

R Musil

3

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

S Dehning

4

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

A Cerovecki

5

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

M Opgen-Rhein

6

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

J Matz

7

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

M Obermeier

9

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

R R Engel

10

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

N Müller

11

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

I Spellmann

13

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

publication date

1 March 2010

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Human Psychopharmacology

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

25

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

116-125

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Clinical correlates of memory in schizophrenia: differential links between depression, positive and negative symptoms, and two types of memory impairment

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1101

21 January 2018

Auditory working memory and Wisconsin Card Sorting Test performance in schizophrenia.

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1101

21 January 2018

Neuropsychological deficits in schizophrenics. Relationship to age, chronicity, and dementia.

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1101

21 January 2018

Novel methods to deal with publication biases: secondary analysis of antidepressant trials in the FDA trial registry database and related journal publications

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1101

21 January 2018

A comparison of neuropsychological effects of thalamotomy and thalamic stimulation.

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1101

21 January 2018

Relations of symptoms to cognitive deficits in schizophrenia

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1101

21 January 2018

What are the functional consequences of neurocognitive deficits in schizophrenia?

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1101

21 January 2018

Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1101

7 January 2021

based on heuristic

inferred from DOI database lookup

Relationship between psychopathology and cognitive functioning in schizophrenia

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1101

7 January 2021

based on heuristic

inferred from DOI database lookup

Cognitive patterns in subtypes of schizophrenia

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1101

7 January 2021

based on heuristic

inferred from DOI database lookup

Prefrontal neuropsychological impairment and illness duration in schizophrenia: a study of 204 patients in Hong Kong

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1101

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of olanzapine and other antipsychotics on cognitive function in chronic schizophrenia: a longitudinal study

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1101

7 January 2021

based on heuristic

inferred from DOI database lookup

Cognitive effects of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: a randomized, open-label clinical trial (EUFEST).

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1101

7 January 2021

based on heuristic

inferred from DOI database lookup

Are psychotic psychopathology and neurocognition orthogonal? A systematic review of their associations

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1101

7 January 2021

based on heuristic

inferred from DOI database lookup

Age and neuropsychologic function in schizophrenia: a decline in executive abilities beyond that observed in healthy volunteers.

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1101

7 January 2021

based on heuristic

inferred from DOI database lookup

Trail making test: normative values from 287 normal adult controls.

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1101

7 January 2021

based on heuristic

inferred from DOI database lookup

Cognitive improvement after treatment with second-generation antipsychotic medications in first-episode schizophrenia: is it a practice effect?

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1101

7 January 2021

based on heuristic

inferred from DOI database lookup

Coding and recall of categorized material in aphasics

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1101

7 January 2021

based on heuristic

inferred from DOI database lookup

Does self-perceived mood predict more variance in cognitive performance than clinician-rated symptoms in schizophrenia?

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1101

7 January 2021

based on heuristic

inferred from DOI database lookup

Changes in cognitive functioning with risperidone and olanzapine treatment: a large-scale, double-blind, randomized study

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1101

7 January 2021

based on heuristic

inferred from DOI database lookup

Stability and course of neuropsychological deficits in schizophrenia

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1101

7 January 2021

based on heuristic

inferred from DOI database lookup

Correlates of cognitive deficits in first episode schizophrenia

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1101

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of second-generation antipsychotics on cognition: current issues and future challenges

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1101

7 January 2021

based on heuristic

inferred from DOI database lookup

Psychopathology and cognition in schizophrenia spectrum disorders: the role of depressive symptoms

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1101

7 January 2021

based on heuristic

inferred from DOI database lookup

Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1101

7 January 2021

based on heuristic

inferred from DOI database lookup

Longitudinal study of symptoms and cognitive function in chronic schizophrenia.

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1101

7 January 2021

based on heuristic

inferred from DOI database lookup

Changes in neuropsychological functioning following treatment with risperidone, olanzapine, and conventional antipsychotic medications

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1101

7 January 2021

based on heuristic

inferred from DOI database lookup

Reliability and validity of the positive and negative syndrome scale for schizophrenics

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1101

7 January 2021

based on heuristic

inferred from DOI database lookup

The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery.

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1101

7 January 2021

based on heuristic

inferred from DOI database lookup

A pen-and-paper human analogue of a monkey prefrontal cortex activation task: spatial working memory in patients with schizophrenia.

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1101

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of olanzapine, quetiapine, and risperidone on neurocognitive function in early psychosis: a randomized, double-blind 52-week comparison.

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1101

7 January 2021

based on heuristic

inferred from DOI database lookup

The neurocognitive effects of aripiprazole: an open-label comparison with olanzapine

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1101

7 January 2021

based on heuristic

inferred from DOI database lookup

The NIMH-MATRICS consensus statement on negative symptoms

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1101

7 January 2021

based on heuristic

inferred from DOI database lookup

Course of cognitive functioning during the stabilization phase of schizophrenia.

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1101

7 January 2021

based on heuristic

inferred from DOI database lookup

Depression in schizophrenia: I. Association with neuropsychological deficits.

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1101

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized controlled trial of olanzapine versus haloperidol in the treatment of primary negative symptoms and neurocognitive deficits in schizophrenia.

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1101

7 January 2021

based on heuristic

inferred from DOI database lookup

Intermanual and alternate-form equivalence on the trail making tests

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1101

7 January 2021

based on heuristic

inferred from DOI database lookup

Memory and intellectual deficits do not decline with age in schizophrenia

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1101

7 January 2021

based on heuristic

inferred from DOI database lookup

Cognitive-enhancing effects of aripiprazole: a case report

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1101

7 January 2021

based on heuristic

inferred from DOI database lookup

Deficit in schizophrenia: the relationship between negative symptoms and neurocognition

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1101

7 January 2021

based on heuristic

inferred from DOI database lookup

Validity of the Trail Making Test as an Indicator of Organic Brain Damage

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1101

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of olanzapine versus quetiapine on cognitive dysfunctions in patients with an acute episode of schizophrenia

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1101

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of risperidone and quetiapine on cognition in patients with schizophrenia and predominantly negative symptoms.

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1101

7 January 2021

based on heuristic

inferred from DOI database lookup

The effects of olanzapine on neurocognitive functioning in medication-refractory schizophrenia.

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1101

7 January 2021

based on heuristic

inferred from DOI database lookup

Relation of neuroleptic and anticholinergic medication to cognitive functions in schizophrenia

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1101

7 January 2021

based on heuristic

inferred from DOI database lookup

COMPARATIVE STUDIES OF SOME PSYCHOLOGICAL TESTS FOR CEREBRAL DAMAGE.

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1101

7 January 2021

based on heuristic

inferred from DOI database lookup

Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1101

7 January 2021

based on heuristic

inferred from DOI database lookup

Does cognitive function improve with quetiapine in comparison to haloperidol?

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1101

7 January 2021

based on heuristic

inferred from DOI database lookup

Lorazepam impairs both visual and auditory perceptual priming.

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1101

7 January 2021

based on heuristic

inferred from DOI database lookup

Cognition, functioning and quality of life in schizophrenia treatment: results of a one-year randomized controlled trial of olanzapine and quetiapine.

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1101

7 January 2021

based on heuristic

inferred from DOI database lookup

Neurocognitive effects of atypical and conventional antipsychotic drugs in schizophrenia: a naturalistic 6-month follow-up study

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1101

7 January 2021

based on heuristic

inferred from DOI database lookup

A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia.

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1101

7 January 2021

based on heuristic

inferred from DOI database lookup

A meta-analysis of cognitive change with haloperidol in clinical trials of atypical antipsychotics: dose effects and comparison to practice effects.

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1101

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HUP.1101

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42651308&oldid=1964596712"